Funding for this research was provided by:
foundation for the national institutes of health (R01 AG058921, R01 HL92301, R01 DK071891)
Received: 17 June 2021
Accepted: 15 November 2021
First Online: 7 December 2021
: The WFSM Institutional Review Board approved the protocol, and all participants provided written informed consent.
: Not applicable.
: MDS serves on serve on scientific advisory boards for Amgen, Esperion, and Novartis. All other authors declare that they have no competing interests.